Patent classifications
C07D501/52
2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and methods for their use for the diagnosis of tuberculosis
-Lactamase substrates and methods for using the substrates to detect -lactamase and to diagnose tuberculosis.
ANTIMICROBIAL PROCHELATORS TO TARGET DRUG-RESISTANT BACTERIA AND METHODS OF MAKING AND USING THE SAME
The present disclosure provides antibacterial prodrugs and methods of making and using the same.
ANTIMICROBIAL PROCHELATORS TO TARGET DRUG-RESISTANT BACTERIA AND METHODS OF MAKING AND USING THE SAME
The present disclosure provides antibacterial prodrugs and methods of making and using the same.
Photoactivatable Antimicrobial Agents And Therapeutic And Diagnostic Methods Of Using Same
The present invention provides photosensitizer compounds for use in detecting beta-lactamase activity. Methods and kits that utilize the photosensitizer compounds of the invention for the detection of, quantitation of, and classification or typing of microbial beta-lactamases.
Photoactivatable Antimicrobial Agents And Therapeutic And Diagnostic Methods Of Using Same
The present invention provides photosensitizer compounds for use in detecting beta-lactamase activity. Methods and kits that utilize the photosensitizer compounds of the invention for the detection of, quantitation of, and classification or typing of microbial beta-lactamases.
2,7-DISUBSTITUTED CEPHALOSPORIN DERIVATIVES AS BETA-LACTAMASE SUBSTRATES AND METHODS FOR THEIR USE FOR THE DIAGNOSIS OF TUBERCULOSIS
-Lactamase substrates and methods for using the substrates to detect -lactamase and to diagnose tuberculosis.
2,7-DISUBSTITUTED CEPHALOSPORIN DERIVATIVES AS BETA-LACTAMASE SUBSTRATES AND METHODS FOR THEIR USE FOR THE DIAGNOSIS OF TUBERCULOSIS
-Lactamase substrates and methods for using the substrates to detect -lactamase and to diagnose tuberculosis.